首页 | 本学科首页   官方微博 | 高级检索  
检索        

猪苓多糖联合乙肝疫苗治疗慢性乙型肝炎对血清HBV标志的影响
引用本文:郑邦德,刘逢举.猪苓多糖联合乙肝疫苗治疗慢性乙型肝炎对血清HBV标志的影响[J].中华消化杂志,1994,14(1):8-9.
作者姓名:郑邦德  刘逢举
作者单位:兰州医学院传染病研究室
摘    要:观察了猪苓多糖联合乙肝疫苗治疗慢性乙型肝炎对患者血清HBV标志的影响。治疗结束后半年,治疗组HBsAg、抗-HBc,HBeAg和PHSA-R的阴转率分别为60%,0,23.1%和18.8%。抗-HBs无1例阳转,无1例HBV标志全部阴转者。对照组分别为3.9%,0,19.3%和16.3。亦无1例产生抗-HBs。两组HBV标志的转换率差异无显著性(P>0.05)。结果表明:猪苓多糖联合乙肝疫苗对清除和抑制HBV无明显效果。

关 键 词:猪苓多糖,乙肝疫苗,HBV标志

THE EFFECT OF ZHULING DUOTANG AND HEPATITIS B VACCINE ON SERUM HBV MARKERS IN PATIENTSWITH CHRONIC HEPATITS B
Zheng Bang-de,Lu Fun-gu,Xio Pin,et al..THE EFFECT OF ZHULING DUOTANG AND HEPATITIS B VACCINE ON SERUM HBV MARKERS IN PATIENTSWITH CHRONIC HEPATITS B[J].Chinese Journal of Digestion,1994,14(1):8-9.
Authors:Zheng Bang-de  Lu Fun-gu  Xio Pin  
Institution:Zheng Bang-de,Lu Fun-gu,Xio Pin,et al.Research unit of Infectious Diseases,LanZhou Medical COllege
Abstract:his article observes the effect of combined use of ZHULING DUOTANG and hepatitis Bvaccine on serum HBV markers.Half year after discontinuation of the therapy,the clearance rateof HBsAg,HBcAb,HbeAg and PHSA-R is 6.0%,0,23.1%and l8.8% respectively. The clearancerate of control group is 3.9%,0,19.3%and l.3% rspectively. No positive HBsAb is observed.Thereis no significant difference in seroconversion rate of HBV markers between both groups(P>0.05).The results showed that the combined use of ZHULING DUOTANG and hepatitis B vaccinehave not definite effect on the removing and inhibiting of HBV.
Keywords:Zhuling Duotang  HBV markers  Hepatitis B vaccine  Chronic hepatitis B    
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号